Publication

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020

Kannt A, Nygaard Madsen A, Kammermeier C, Elvert R, Klöckener T, Bossart M, Haack T, Evers A, Lorenz K, Hennerici W, Rocher C, Böcskei Z, Guillemot JC, Mikol V, Pattou F, Staels B, Wagner M

View publication

Share this page

Resource Library

Related resources

Publication

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Open

Poster

Development of hepatocellular carcinoma in the extended GAN diet-induced obese mouse model of NASH with advanced fibrosis

Open

Publication

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Open

Poster

Preclinical efficacy and clinical translatability of lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Open

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650